Cautious optimism on IPF in new position statement
By Michael Woodhead
5 Feb 2018
New antifibrotic drugs have revolutionised the management of idiopathic pulmonary fibrosis but it remains a progressive and fatal disease that requires people to prepare for the worst, according to a new position statement from the Thoracic Society of Australia & New Zealand and the Lung Foundation. Published in the MJA, the position statement on IPF ...